Lessons from ISAR-REACT 5 about which antiplatelet agent to choose in ACS patients
This video was recorded at the ESC in Paris, France, on September 2, 2019.
Prof. Freek Verheugt, cardiologist, Amsterdam, The Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: